Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
Sodium channel inhibitor drugs decrease pathological hyperactivity in various diseases including pain syndromes, myotonia, arrhythmias, nerve injuries and epilepsies. Inhibiting pathological but not physiological activity, however, is a major challenge in drug development. Sodium channel inhibitors...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | journal article |
| Published: |
2018
|
| Online Access: | http://hdl.handle.net/10831/67111 |
| Tags: |
Add Tag
Be the first to tag this record!
|